The challanges are many for a small, public company developing its own technology on a global market. With guidence and active participation from the Miris Board of Directors, the CEO and Management Team are able to navigate all aspects of the business. Their dedication, knowledge and expertise are instrumental in ensuring Miris reaches it potential.
Chairman of the Board
Ingemar Kihlström
Members of the Board
Inger Andersson
Niklas Dahl
Sören Densjö
"It is a privilege to be part of the development of future individual nutrition for preterm neonates by the engagement in the BoD of Miris Holding."
Work outside of Miris
Independent consultant for Ingemar Kihlström AB, in the life science area.
Short history
Associate professor at Uppsala University. More than 15 years of experience in pharmaceutical and business development for Astra and Pharmacia. Ten years of experience in financing as well as analyst and corporate advisor in life sciences. Chairman of the Board at Artimplant AB, MedCap AB, Prolight Diagnostics AB, Karocell Tissue Engineering, Acromed AB, member of the board at companies in several Nordic countries
Shares in Miris Holding AB: 8 672 265 shares, 2 890 755 options
"To be able to contribute to individual nutrition for preterm babies feels like one of the most important tasks one can get. For me, it was therefore a given to say yes to be part of the Board."
Work outside of Miris
Independent consultant focused on management and advising in the food sector 2013–
Short history
Director general, National Food Agency 2004–2013
Senior vice President Operations, Vin & Sprit 2002–2004
Director Operations, Arla Foods/ Arla Färskvaror 2000–2002
CEO Arla R&D, Technical Director, Environmental Manager etc. and other posts in Arla 1974–2000
Shares in Miris Holding AB: 0 shares
"Miris missions are highly motivating. The goals comply with my ambitions to implement science and proven experiences in health care, aspiring to improved survival and health for premature children."
Work outside of Miris
Full professor and senior consultant at Uppsala University/Uppsala University Hospital.
Short history
Thirty-five years of clinical experience in Pediatrics and Genetics. Researcher at INSERM/University of Strasbourg for two years. Consultant at Astra-Zeneca for four years. Advisor at the European Research Council. Originator of five patents in biomedicine.
Shares in Miris Holding AB: 0 shares
”Miris mission is to make individual nutrition, based on breast milk, available globally to improve preterm health. It is encouraging to participate in the Board work for this important task. Hopefully my long experience in communication will be useful.”
Work outside Miris:
Independent consultant in communication and investor relations for companies in the life science sector through Densjö Kommunikation AB during the past 20 years.
Short history
Master of Political Science, Uppsala University. Previous positions in the Ministry of Finance and the Federation of Swedish Industries. Director External Communication in the listed companies Pharmacia, Procordia and Pharmacia & Upjohn for a total of 20 years. Mentor for communications managers and for 10 years board member of Swedish Communication Association
Shares in Miris Holding AB: 0 shares
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to info@mirissolutions.com.
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to order@mirissolutions.com.
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to support@mirissolutions.com.